Patent US5437272A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5437272A Expired / Lapsed US ⏱️ 0.0 years remaining

Perfluorocarbon associated gas exchange

Assignee: Alliance Pharmaceutical Corp
•
Filing: 1991-05-01
•
Granted: 1995-08-01
•
Expires: 2011-05-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Method and means for maintaining respiratory gas exchange, by introducing into the pulmonary air passages of a mammalian host a volume of perfluorocarbon liquid substantially equivalent to the pulmonary functional residual capacity of the host, maintaining respiratory gas exchange in the perfluorocarbon liquid-laden pulmonary air passages by continuous positive pressure breathing with a conventional respirator, for up to an hour or more, and thereafter evaporating the perfluorocarbon liquid from the pulmonary air passages. Useful for treating pulmonary surfactant deficiency or dysfunction.

Inventors

  • 👤 Bradley P. Fuhrman

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 13:09
CPC Classifications
A; A61; A61M; A61M16/00; A61M16/0054; A61M16/08; A61M16/0816; A61M16/0841; A61P; A61P11/00; A61M16/0833; A61M16/0003; A61M2016/0027; A61M2202/00; A61M2202/04; A61M2202/0468; A61M2202/0476; Y; Y10; Y10S; Y10S128/00; Y10S128/913

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 102 words
A method for maintaining respiratory gas exchange, comprising the steps of: first introducing into the pulmonary air passages of a mammalian host a volume of perfluorocarbon liquid from about 50% to not more than about 100% of the pulmonary functional residual capacity of the host; and then physically admixing a volume of breathing gas with said introduced volume of perfluorocarbon liquid in the pulmonary air passages whereby said breathing gas forms bubbles inside said liquid-containing pulmonary air passages so that oxygenation of said perfluorocarbon liquid takes place in vivo, said admixing resulting when said host takes multiple breaths of a breathing gas.
Claim 2
Independent Claim 102 words
A method for maintaining respiratory gas exchange, comprising the steps of: first introducing into the pulmonary air passages of a mammalian host a volume of perfluorocarbon liquid from about 50% to not more than about 100% of the pulmonary functional residual capacity of the host; and then physically admixing a volume of breathing gas with said introduced volume of perfluorocarbon liquid in the pulmonary air passages whereby said breathing gas forms bubbles inside said liquid-containing pulmonary air passages so that oxygenation of said perfluorocarbon liquid takes place in vivo, said admixing resulting when said host takes multiple breaths of a breathing gas.
Claim 3
Dependent Claim 33 words
The method of claim 1, wherein continuous positive pressure gas breathing is provided into a patient's perfluorocarbon liquid-containing pulmonary air passages by a volume-regulated, timed-cycle gas respirator or a pressure-limited, timed-cycle gas respirator.
Claim 4
Dependent Claim 28 words
The method of claim 1, wherein the volume of perfluorocarbon liquid is maintained substantially equivalent to the pulmonary functional residual capacity of a host throughout the treatment period.
Claim 5
Dependent Claim 22 words
The method of claim 1, wherein after the treatment period the perfluorocarbon liquid is removed from a patient's air passages by evaporation.
Claim 6
Dependent Claim 15 words
The method of claim 1, wherein the perfluorocarbon liquid comprises a pharmacologic or diagnostic agent.
Claim 7
Dependent Claim 32 words
The method of claim 1 wherein the volume of perfluorocarbon liquid introduced into a patient's pulmonary air passages is at least about 1/2 of the pulmonary functional residual capacity of the host.
Claim 8
Dependent Claim 32 words
The method of claim 1 wherein the volume of perfluorocarbon liquid introduced into a patient's pulmonary air passages is at least about 3/4 of the pulmonary functional residual capacity of the host.
Claim 9
Dependent Claim 22 words
The method of claim 1, wherein said breathing gas is moved into and out of the host's lungs by a gas ventilator.
Claim 10
Dependent Claim 11 words
The method of claim 1, wherein said perfluorocarbon liquid is halogenated.
Claim 11
Dependent Claim 12 words
The method of claim 1, wherein said perfluorocarbon liquid is perfluorooctyl bromide.
Claim 12
Dependent Claim 20 words
The method of claim 1, wherein said introducing step is performed on a host having pulmonary surfactant deficiency or dysfunction.
Claim 13
Dependent Claim 18 words
The method of claim 1, wherein said introducing step is performed on a host in need of resuscitation.
Claim 14
Dependent Claim 11 words
The method of claim 12, wherein said resuscitation is cardiopulmonary resuscitation.
Claim 15
Independent Claim 170 words
A device for regulating fluid flow during perfluorocarbon associated gas exchange, comprising: first and second conduits having distal and proximal ends, an endotracheal tube, a chamber adapted for establishing fluid communication between said endotracheal tube and said conduits, said chamber interposed between said conduits and said endotracheal tube, at least one valve connected to said conduits to reversibly establish fluid communication between said chamber and either the proximal end of the first but not the second conduit, or the proximal end of the second but not the first conduit, means associated with said first conduit to introduce and remove a perfluorocarbon liquid to and from said chamber and into a lung, and means associated with said second conduit to introduce and remove breathing gas separate and apart from said perfluorocarbon liquid to and from said chamber to permit a patient into whom the endotracheal tube is introduced to breathe a breathing gas into and out of perfluorocarbon-containing pulmonary passages into which said perfluorocarbon liquid has been introduced by said device.
Claim 16
Independent Claim 170 words
A device for regulating fluid flow during perfluorocarbon associated gas exchange, comprising: first and second conduits having distal and proximal ends, an endotracheal tube, a chamber adapted for establishing fluid communication between said endotracheal tube and said conduits, said chamber interposed between said conduits and said endotracheal tube, at least one valve connected to said conduits to reversibly establish fluid communication between said chamber and either the proximal end of the first but not the second conduit, or the proximal end of the second but not the first conduit, means associated with said first conduit to introduce and remove a perfluorocarbon liquid to and from said chamber and into a lung, and means associated with said second conduit to introduce and remove breathing gas separate and apart from said perfluorocarbon liquid to and from said chamber to permit a patient into whom the endotracheal tube is introduced to breathe a breathing gas into and out of perfluorocarbon-containing pulmonary passages into which said perfluorocarbon liquid has been introduced by said device.
Claim 17
Dependent Claim 32 words
The device of claim 14, wherein the first conduit comprises first, second, and third channels having proximal ends that collectively establish fluid communication with the chamber as regulated by the valve means.
Claim 18
Dependent Claim 20 words
The device of claim 14, wherein the second conduit comprises a single channel having an aperture to the ambient environment.
Claim 19
Dependent Claim 52 words
The device of claim 16, wherein the valve means opens the aperture to the ambient environment when fluid communication is established between the chamber and the first but not the second conduit, and closes the aperture when fluid communication is established between the chamber and the second but not the first conduit.
Claim 20
Independent Claim 133 words
A system for implementing perfluorocarbon associated gas exchange, comprising: a device for first introducing perfluorocarbon liquid into a patient's pulmonary air passages, a gas ventilator for maintaining respiratory gas exchange in a patient's perfluorocarbon liquid-containing pulmonary air passages including means for secondly introducing and removing multiple breaths of breathing gas into said passages during a treatment period separate and apart from said introduction of said perfluorocarbon liquid so that said breathing gas physically admixes with said perfluorocarbon liquid in said pulmonary air passages, of a patient whereby a patient's pulmonary air passages simultaneously contain both said breathing gas and said perfluorocarbon liquid, and a device operably associated with both said introducing device and said gas ventilator for regulating the aforesaid introduction of liquid and introduction and removal of gas during the treatment period.
Claim 21
Independent Claim 133 words
A system for implementing perfluorocarbon associated gas exchange, comprising: a device for first introducing perfluorocarbon liquid into a patient's pulmonary air passages, a gas ventilator for maintaining respiratory gas exchange in a patient's perfluorocarbon liquid-containing pulmonary air passages including means for secondly introducing and removing multiple breaths of breathing gas into said passages during a treatment period separate and apart from said introduction of said perfluorocarbon liquid so that said breathing gas physically admixes with said perfluorocarbon liquid in said pulmonary air passages, of a patient whereby a patient's pulmonary air passages simultaneously contain both said breathing gas and said perfluorocarbon liquid, and a device operably associated with both said introducing device and said gas ventilator for regulating the aforesaid introduction of liquid and introduction and removal of gas during the treatment period.

References Cited (Backward Citations)

US3975512A Cited
US4036210A Cited
SU858824A1 Cited
SU1143420A1 Cited
US4825859A Cited
US5024995A Cited
WO1991003267A1 Cited
US5029580A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1998-07-31 1999-01-30 1999-08-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2002-07-31 2003-01-30 2003-08-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2006-07-31 2007-01-30 2007-08-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag